Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
2022-03-07
1X40 RH PART OF FCL SAID TO CONTAIN 517 CARTOEUTICALS AS UNDER MOMETASONE FUROATE OINTMENT0.1 15GM NDC CODE68462022517 FDA PROD
1X40 RH PART OF FCL SAID TO CONTAIN 517 CARTOEUTICALS AS UNDER MOMETASONE FUROATE OINTMENT0.1 15GM NDC CODE68462022517 FDA PROD
53306, MUNDRA
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5,015
KG
517
CTN
***
USD
2021-02-11
9 PALLET CONTAINING 526 CA RTONS PHARMACEUTICALS AS UNDER PRAVASTATIN SODIU M TAB 20MG 90 S NDC CODE:6 8462019690 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO.:3004.90.92.20 ANDA NO .:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMICPOTASSIUM CL ER CAPS 10MEQ (750MG) 500 S NDC CODE:68462035705 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.:3004.9 0.92.90 ANDA NO.: 20 2868 T HERAPEUTICE USE: -TREATMEN T OR PREVENTION OF HYPOKAL EMIA 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO.F20087 001593 DT. 07.01.2021 F200 87001594 DT. 07.01.2021 N ET WT: 1008.367 FREIGHT PR EPAID THE TEMPERATURE TO BE SET AT 20 DEGREES CELC IUS IN ACCORDANCE W ITH SHI PPER S INSTRUCTIONS
9 PALLET CONTAINING 526 CA RTONS PHARMACEUTICALS AS UNDER PRAVASTATIN SODIU M TAB 20MG 90 S NDC CODE:6 8462019690 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO.:3004.90.92.20 ANDA NO .:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMICPOTASSIUM CL ER CAPS 10MEQ (750MG) 500 S NDC CODE:68462035705 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.:3004.9 0.92.90 ANDA NO.: 20 2868 T HERAPEUTICE USE: -TREATMEN T OR PREVENTION OF HYPOKAL EMIA 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO.F20087 001593 DT. 07.01.2021 F200 87001594 DT. 07.01.2021 N ET WT: 1008.367 FREIGHT PR EPAID THE TEMPERATURE TO BE SET AT 20 DEGREES CELC IUS IN ACCORDANCE W ITH SHI PPER S INSTRUCTIONS
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1,863
KG
9
PKG
***
USD
2020-11-24
10 PALLET CONTAINING 457 C ARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPS 10MEQ (750MG) 100 S NDC C ODE:68462035701 FDA PRODUC T CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AND A NO.:202868 THERAPEUTICE USE: -TREATMENT OR PREVENT ION OF HYPOKALEM
10 PALLET CONTAINING 457 C ARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPS 10MEQ (750MG) 100 S NDC C ODE:68462035701 FDA PRODUC T CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AND A NO.:202868 THERAPEUTICE USE: -TREATMENT OR PREVENT ION OF HYPOKALEM
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1,997
KG
10
PKG
***
USD
2020-09-18
24 PALLETS CONTAINING 408 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
24 PALLETS CONTAINING 408 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3,619
KG
24
PKG
***
USD
2020-08-06
36 PALLETS CONTAINING 823 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AN DA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVE NTION OF HYPOKALE
36 PALLETS CONTAINING 823 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AN DA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVE NTION OF HYPOKALE
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6,071
KG
36
PKG
***
USD
2020-09-26
24 PALLETS CONTAINING 457 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
24 PALLETS CONTAINING 457 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3,620
KG
24
PKG
***
USD
2021-02-22
PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO. 65 R C F 14 H. T. S NO. 3 004.90.92.90 3004.90.92.30 3004.90.
PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO. 65 R C F 14 H. T. S NO. 3 004.90.92.90 3004.90.92.30 3004.90.
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7,693
KG
30
PKG
***
USD
2020-08-26
PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO.65 R C F 14 H. T. S NO. 30 04.90.92.90 3004.90.92.20
PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO.65 R C F 14 H. T. S NO. 30 04.90.92.90 3004.90.92.20
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2,863
KG
20
PKG
***
USD
2022-06-08
14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA
14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3,034
KG
14
PKG
***
USD
2021-02-11
27 PALLET CONTAINING 808 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC URSODIOL TABS 500MG 100 S NDC C ODE:68462047401 FDA PRODUCT CODE NO.:63 N C A 25 H. T. S NO.:3004.49.00 .10 ANDA NO.: 90-8 01 THER APEUTICE USE: - FOR THE TR EATMENT O F PATIENTS WITH P RIMARY BILIARY CIRRHOSIS T HE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHO SIS 02 DATA LOGGERS HUMI DITY:65% S ET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2004008 DT. 08.01.2021 NE T WT: 5607.01 FREIGHT PR EPAID THE TEMPE RATURE T O BE SET AT +20 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS
27 PALLET CONTAINING 808 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC URSODIOL TABS 500MG 100 S NDC C ODE:68462047401 FDA PRODUCT CODE NO.:63 N C A 25 H. T. S NO.:3004.49.00 .10 ANDA NO.: 90-8 01 THER APEUTICE USE: - FOR THE TR EATMENT O F PATIENTS WITH P RIMARY BILIARY CIRRHOSIS T HE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHO SIS 02 DATA LOGGERS HUMI DITY:65% S ET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2004008 DT. 08.01.2021 NE T WT: 5607.01 FREIGHT PR EPAID THE TEMPE RATURE T O BE SET AT +20 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6,417
KG
27
PKG
***
USD